RNS Number : 4449E Renalytix AI PLC 06 November 2020 Renalytix AI plc (" RenalytixAI " or the " Company ") Change of adviser NEW YORK , November 6, 2020 - Renalytix AI plc (LSE : RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on
RNS Number : 9886D Renalytix AI PLC 02 November 2020 Renalytix AI plc (" RenalytixAI " or the " Company ") Posting of Annual Report & Accounts and Notice of AGM NEW YORK , November 2, 2020 - Renalytix AI plc (LSE : RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro
RNS Number : 3088D Renalytix AI PLC 27 October 2020 Renalytix AI plc (" RenalytixAI " or the " Company ") Full Year Report NEW YORK , October 27, 2020 - Renalytix AI plc (LSE : RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing
RNS Number : 2682C Renalytix AI PLC 16 October 2020 Renalytix AI plc (" RenalytixAI " or the " Company ") Notice of results Analyst and Investor presentations RenalytixAI To Announce Financial Results for Full Year Ended June 30, 2020 and Provide Corporate Update NEW YORK , October 16,
RNS Number : 9631B Renalytix AI PLC 13 October 2020 Not for release, publication or distribution, directly or indirectly, in whole or in part, in, into or within the United States , Australia , Canada , Hong Kong , Japan , New Zealand , the Republic of South Africa or any other jurisdiction where
RNS Number : 6495Z Renalytix AI PLC 22 September 2020 This announcement contains inside information Renalytix AI plc ("RenalytixAI", the "Company") RenalytixAI Receives California Commercial Laboratory Certification RenalytixAI is now currently licensed to provide KidneyIntelX testing
RNS Number : 4123Z Renalytix AI PLC 18 September 2020 This announcement contains inside information Renalytix AI plc ("RenalytixAI", the "Company") RenalytixAI Reaches Milestone of KidneyIntelX Commercial Testing with Mount Sinai Health System NEW YORK , September 18, 2020 - Renalytix AI
RNS Number : 7366X Renalytix AI PLC 02 September 2020 Renalytix AI plc ("RenalytixAI", the "Company") Grant of Purchase Rights under the 2020 Employee Share Purchase Plan and Verici update NEW YORK , September 2, 2020 - Renalytix AI plc ( LSE: RENX) (NASDAQ: RNLX) announces that on 28
RNS Number : 1457X Renalytix AI PLC 26 August 2020 Renalytix AI plc ("RenalytixAI", the "Company") RenalytixAI Files Submission Seeking U.S. FDA Clearance of KidneyIntelX NEW YORK , August 26, 2020 - Renalytix AI plc ( LSE: RENX) (NASDAQ: RNLX), an artificial intelligence -enabled in vitro
RNS Number : 7551W Renalytix AI PLC 21 August 2020 Renalytix AI plc ("RenalytixAI", the "Company") RenalytixAI to Collaborate with AstraZeneca to Improve Outcomes for Patients with Chronic Disease Parties to adopt multi-phase approach to develop precision medicine strategies to optimize
